Taysha Gene Therapies Net Profit Margin Growth & History (TSHA)

Taysha Gene Therapies's net profit margin was −1,115.27% for fiscal 2025.

View full Taysha Gene Therapies company overview

Taysha Gene Therapies annual net profit margin history

Taysha Gene Therapies annual net profit margin

Fiscal yearPeriod endedNet profit marginChange (percentage points)
20252025-12-31−1,115.27%−43.65 pp
20242024-12-31−1,071.62%−349.56 pp
20232023-12-31−722.06%+5913.19 pp
20222022-12-31−6,635.25%

Taysha Gene Therapies net profit margin trends

Between the periods ended 2022-12-31 and 2025-12-31, Taysha Gene Therapies's net profit margin increased from −6,635.25% to −1,115.27%, a change of +5519.99 percentage points. The latest reported quarter, Q4 2025, shows −507.77%.

About the metric

What net profit margin means

Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.

Calculation and source

How net profit margin is calculated

TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Taysha Gene Therapies source filings ↗

Community posts

It’s quiet here.

No posts about TSHA yet. Start the conversation.

Write the first post